Vivos (RDGL) Operating Income Growth (3y) (2013 - 2025)
Vivos (RDGL) Operating Income Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -24.91% |
| 10 | Vivos | - | - | -3,105.00 | -15.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.80% |
| Sep 30, 2025 | -24.22% |
| Jun 30, 2025 | 5.02% |
| Mar 31, 2025 | -4.93% |
| Dec 31, 2024 | -44.70% |
| Sep 30, 2024 | -63.03% |
| Jun 30, 2024 | 34.44% |
| Mar 31, 2024 | -34.90% |
| Dec 31, 2023 | -47.26% |
| Sep 30, 2023 | -74.94% |
| Jun 30, 2023 | -92.37% |
| Mar 31, 2023 | -27.30% |
| Dec 31, 2022 | -29.55% |
| Sep 30, 2022 | 23.01% |
| Jun 30, 2022 | -65.73% |
| Mar 31, 2022 | -49.17% |
| Dec 31, 2021 | 49.77% |
| Sep 30, 2021 | -12.43% |
| Jun 30, 2021 | -75.68% |
| Mar 31, 2021 | 6.40% |